Your browser doesn't support javascript.
loading
Activity of sirolimus in patients with progressive epithelioid hemangioendothelioma: A case-series analysis within the Italian Rare Cancer Network.
Stacchiotti, Silvia; Simeone, Noemi; Lo Vullo, Salvatore; Baldi, Giacomo G; Brunello, Antonella; Vincenzi, Bruno; Palassini, Elena; Dagrada, GianPaolo; Collini, Paola; Morosi, Carlo; Greco, Francesca G; Sbaraglia, Marta; Dei Tos, Angelo P; Mariani, Luigi; Frezza, Anna Maria; Casali, Paolo G.
Afiliação
  • Stacchiotti S; Department of Medical Oncology, IRCCS Foundation National Cancer Institute, Milan, Italy.
  • Simeone N; Department of Medical Oncology, IRCCS Foundation National Cancer Institute, Milan, Italy.
  • Lo Vullo S; Unit of Clinical Epidemiology and Trial Organization, IRCCS Foundation National Cancer Institute, Milan, Italy.
  • Baldi GG; Department of Medical Oncology, Santo Stefano Hospital, Prato, Italy.
  • Brunello A; Department of Oncology, Medical Oncology Unit 1, Veneto Institute of Oncology, IRCCS, Padua, Italy.
  • Vincenzi B; Department of Medical Oncology, Biomedical Campus, University of Rome, Rome, Italy.
  • Palassini E; Department of Medical Oncology, IRCCS Foundation National Cancer Institute, Milan, Italy.
  • Dagrada G; Department of Diagnostic Pathology and Laboratory Medicine, IRCCS Foundation National Cancer Institute, Milan, Italy.
  • Collini P; Department of Diagnostic Pathology and Laboratory Medicine, IRCCS Foundation National Cancer Institute, Milan, Italy.
  • Morosi C; Department of Radiology, IRCCS Foundation National Cancer Institute, Milan, Italy.
  • Greco FG; Department of Radiology, IRCCS Foundation National Cancer Institute, Milan, Italy.
  • Sbaraglia M; Department of Pathology, University of Padua Foundation, Padua, Italy.
  • Dei Tos AP; Department of Pathology, University of Padua Foundation, Padua, Italy.
  • Mariani L; Department of Medicine, University of Padua, Padua, Italy.
  • Frezza AM; Unit of Clinical Epidemiology and Trial Organization, IRCCS Foundation National Cancer Institute, Milan, Italy.
  • Casali PG; Department of Medical Oncology, IRCCS Foundation National Cancer Institute, Milan, Italy.
Cancer ; 127(4): 569-576, 2021 02 15.
Article em En | MEDLINE | ID: mdl-33107985
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Hemangioendotelioma Epitelioide / Sirolimo / Peptídeos e Proteínas de Sinalização Intracelular Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Child / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Hemangioendotelioma Epitelioide / Sirolimo / Peptídeos e Proteínas de Sinalização Intracelular Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Child / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Ano de publicação: 2021 Tipo de documento: Article